The pseudopeptide HB-19 binds to cell surface nucleolin and inhibits angiogenesis

Vascular Cell

Volumn 4, Issue , 2012, Pages

  Birmpas, Charalampos ^a   Briand, Jean Paul ^b   Courty, Jos ^c   Katsoris, Panagiotis ^a  

^a UNIVERSITY OF PATRAS   (Greece)

^b UNIVERSITÉ PARIS EST CRÉTEIL   (France)

^c INSTITUT DE BIOLOGIE MOLÉCULAIRE ET CELLULAIRE   (France)

Author keywords

[No Author keywords available]

Indexed keywords

FOCAL ADHESION KINASE; GELATINASE A; MITOGEN ACTIVATED PROTEIN KINASE 3; NUCLEOLIN; PROTEIN HB 19; PSEUDOPEPTIDE; SMALL INTERFERING RNA; UNCLASSIFIED DRUG;

ANGIOGENESIS; APOPTOSIS; ARTICLE; CANCER INHIBITION; CELL ADHESION; CELL MIGRATION; CELL PROLIFERATION; CELL SURVIVAL; CONTROLLED STUDY; DOWN REGULATION; HUMAN; HUMAN CELL; IN VITRO STUDY; PRIORITY JOURNAL; PROTEIN BINDING; PROTEIN EXPRESSION; PROTEIN PHOSPHORYLATION; UMBILICAL VEIN ENDOTHELIAL CELL;

EID: 84875438321     PISSN: None     EISSN: 2045824X     Source Type: Journal    
DOI: 10.1186/2045-824X-4-21     Document Type: Article

References (60)

1. Molecular dissection of nucleolin's role in growth and cell proliferation: new insights. Srivastava M, Pollard HB, FASEB J 1999 13 1911 1922 10544174 (Pubitemid 29517621)
2. Functions of the histone chaperone nucleolin in diseases. Storck S, Shukla M, Dimitrov S, Bouvet P, Subcell Biochem 2007 41 125 144 10.1007/1-4020-5466-1-7 17484127
3. The cell-surface-expressed nucleolin is associated with the actin cytoskeleton. Hovanessian AG, Puvion-Dutilleul F, Nisole S, Svab J, Perret E, Deng JS, Krust B, Exp Cell Res 2000 261 312 328 10.1006/excr.2000.5071 11112338 (Pubitemid 32010228)
4. Nucleolin undergoes partial N- and O-glycosylations in the extranuclear cell compartment. Carpentier M, Morelle W, Coddeville B, Pons A, Masson M, Mazurier J, Legrand D, Biochemisty 2005 44 5804 5814 10.1021/bi047831s (Pubitemid 40525117)
5. A protein partially expressed on the surface of HepG2 cells that binds lipoproteins specifically is nucleolin. Semenkovich CF, Ostlund REJ, Olson MO, Yang JW, Biochemistry 1990 29 9708 9713 10.1021/bi00493a028 2176855 (Pubitemid 20355221)
6. Nucleolin expressed at the cell surface is a marker of endothelial cells in angiogenic blood vessels. Christian S, Pilch J, Akerman ME, Porkka K, Laakkonen P, Ruoslahti E, J Cell Biol 2003 163 871 878 10.1083/jcb.200304132 14638862 (Pubitemid 37517893)
7. Surface expressed nucleolin is constantly induced in tumor cells to mediate calcium-dependent ligand internalization. Hovanessian AG, Soundaramourty C, El Khoury D, Nondier I, Svab J, Krust B, PLoS One 2010 5 15787 10.1371/journal.pone.0015787 21203423
8. The angiogenesis function of nucleolin is mediated by vascular endothelial growth factor and nonmuscle myosin. Huang Y, Shi HHZ, Song X, Yuan S, Luo Y, Blood 2006 107 3564 3571 10.1182/blood-2005-07-2961 16403913
9. The anti-HIV pentameric pseudopeptide HB-19 binds the C-terminal end of nucleolin and prevents anchorage of virus particles in the plasma membrane of target cells. Nisole S, Said EA, Mische C, Prevost MC, Krust B, Bouvet P, Bianco A, Briand JP, Hovanessian AG, J Biol Chem 2002 277 20877 20886 10.1074/jbc.M110024200 11919179 (Pubitemid 34967396)
10. The anti-HIV cytokine midkine binds the cell-surface-expressed nucleolin as a low affinity receptor. Said AE, Krust B, Nisole S, Briand JP, Hovanessian AG, J Biol Chem 2002 277 37492 37502 10.1074/jbc.M201194200 12147681
11. Pleiotrophin inhibits HIV infection by binding the cell surface expressed nucleolin. Said EA, Courty J, Svab J, Delbé J, Krust B, Hovanessian AG, FEBS J 2005 272 4646 4659 10.1111/j.1742-4658.2005.04870.x 16156786 (Pubitemid 41366988)
12. Surface nucleolin participates in both the binding and endocytosis of lactoferrin in target cells. Legrand D, Vigie K, Said EA, Elass E, Masson M, Slomianny MC, Carpentier M, Briand JP, Mazurier J, Hovanessian AG, Eur J Biochem 2004 271 303 317 10.1046/j.1432-1033.2003.03929.x 14717698 (Pubitemid 38130458)
13. Urokinase-induced mitogenesis is mediated by casein kinase 2 and nucleolin. Dumler I, Stepanova V, Jerke U, Mayboroda OA, Vogel F, Bouvet P, Tkachuk V, Haller H, Gulba DC, Curr Biol 1999 9 1468 1476 10.1016/S0960-9822(00) 80116-5 10607589 (Pubitemid 30023481)
14. Nuclear translocation of urokinase-type plasminogen activator. Stepanova V, Lebedeva T, Kuo A, Yarovoi S, Tkachuk S, Zaitsev S, Bdeir K, Dumler I, Marks MS, Parfyonova Y, Tkachuk VA, Higazi AA, Cines DB, Blood 2008 112 100 110 10.1182/blood-2007-07-104455 18337556
15. Identification of a 110-kDa nonintegrin cell surface laminin-binding protein which recognizes an A chain neurite-promoting peptide. Kleinman HK, Weeks BS, Cannon FB, Sweeney TM, Sephel GC, Clement B, Zain M, Olson MO, Jucker M, Burrous BA, Arch Biochem Biophys 1991 290 320 325 10.1016/0003-9861(91)90547- V 1834017
16. Identification of nucleolin as a new L-selectin ligand. Harms G, Kraft R, Grelle G, Volz B, Dernedde J, Tauber R, Biochem J 2001 360 531 538 10.1042/0264-6021:3600531 11736641 (Pubitemid 34020257)
17. Cellular adhesion mediated by factor J, a complement inhibitor. Evidence for nucleolin involvement. Larrucea S, Gonza-lez-Rubio C, Cambronero R, Ballou B, Bonay P, Lopez-Granados E, Bouvet P, Fontán G, Fresno M, López-Trascasa M, J Biol Chem 1998 273 31718 31725 10.1074/jbc.273.48. 31718 9822633 (Pubitemid 29177101)
18. Cell-surface nucleolin is a signal transducing P-selectin binding protein for human colon carcinoma cells. Reyes-Reyes EM, Akiyama SK, Exp Cell Res 2008 314 2212 2223 10.1016/j.yexcr.2008.03.016 18504038
19. Effect of laminin-1 on intestinal cell differentiation involves inhibition of nuclear nucleolin. Turck N, Lefebvre O, Gross I, Gendry P, Kedinger M, Simon-Assmann P, Launay JF, J Cell Physiol 2006 206 545 555 10.1002/jcp.20501 16245305 (Pubitemid 43062826)
20. Discovery and development of the G-rich oligonucleotide AS1411 as a novel treatment for cancer. Bates PJ, Laber DA, Miller DM, Thomas SD, Trent JO, Exp Mol Pathol 2009 86 151 164 10.1016/j.yexmp.2009.01.004 19454272
21. Treatment of peritoneal carcinomatosis by targeted delivery of the radio-labeled tumor homing peptide bi-DTPA-[F3]2 into the nucleus of tumor cells. Drecoll E, Gaertner FC, Miederer M, Blechert B, Vallon M, Müller JM, Alke A, Seidl C, Bruchertseifer F, Morgenstern A, Senekowitsch-Schmidtke R, Essler M, PLoS One 2009 4 5715 10.1371/journal.pone.0005715 19479088
22. Nucleolin is a receptor that mediates antiangiogenic and antitumor activity of endostatin. Shi H, Huang Y, Zhou H, Song X, Yuan S, Fu Y, Luo Y, Blood 2007 110 2899 2906 10.1182/blood-2007-01-064428 17615292 (Pubitemid 350006943)
23. Cell surface nucleolin antagonist causes endothelial cell apoptosis and normalization of tumor vasculature. Fogal V, Sugahara KN, Ruoslahti E, Christian S, Angiogenesis 2009 12 91 100 10.1007/s10456-009-9137-5 19225898
24. Suppression of tumor growth and angiogenesis by a specific antagonist of the cell-surface expressed nucleolin. Destouches D, El Khoury D, Hamma-Kourbali Y, Krust B, Albanese P, Katsoris P, Guichard G, Briand JP, Courty J, Hovanessian AG, PLoS One 2008 3 2518 10.1371/journal.pone.0002518 18560571
25. Culture of human endothelial cells derived from umbilical veins. Identification by morphologic and immunologic criteria. Jaffe EA, Nachman RL, Becker CG, Minick CR, J Clin Invest 1973 52 2745 2756 10.1172/JCI107470 4355998
26. Characterization of heparin affin regulatory peptide signaling in human endothelial cells. Polykratis A, Katsoris P, Courty J, Papadimitriou E, J Biol Chem 2005 280 22454 22461 10.1074/jbc.M414407200 15797857 (Pubitemid 40827901)
27. Endothelial cell regulation of matrix metalloproteinases. Haas TL, Can J Physiol Pharmacol 2005 83 1 7 10.1139/y04-120 15759044 (Pubitemid 40754769)
28. Vascular remodeling and protease inhibition-bench to bedside. Sluijter JP, de Kleijn DP, Pasterkamp G, Cardiovasc Res 2006 69 595 603 10.1016/j.cardiores.2005.11.026 16387286 (Pubitemid 43139723)
29. Matrix metalloproteinases and tumor metastasis. Deryugina EI, Quigley JP, Cancer Metastasis Rev 2006 25 9 34 10.1007/s10555-006-7886-9 16680569 (Pubitemid 43723979)
30. VEGF-receptor signal transduction. Cross M, Dixelius J, Matsumoto T, Claesson-Welsh L, Trends Biochem Sci 2003 28 488 494 Review 10.1016/S0968- 0004(03)00193-2 13678960 (Pubitemid 38340413)
31. Focal adhesion kinase and its signaling pathways in cell migration and angiogenesis. Zhao X, Guan JL, Adv Drug Deliv Rev 2011 63 610 615 10.1016/j.addr.2010.11.001 21118706
32. The anti-HIV pseudopeptide HB-19 forms a complex with the cell-surface-expressed nucleolin independent of heparan sulfate proteoglycans. Nisole S, Krust B, Callebaut C, Guichard G, Muller S, Briand JP, Hovanessian AG, J Biol Chem 1999 274 27875 27884 10.1074/jbc.274.39.27875 10488134 (Pubitemid 29458042)
33. Targeting surface nucleolin with multivalent HB-19 and related Nucant pseudopeptides results in distinct inhibitory mechanisms depending on the malignant tumor cell type. Krust B, El Khoury D, Nondier I, Soundaramourty C, Hovanessian AG, BMC Cancer 2011 11 333 10.1186/1471-2407-11-333 21812966
34. Anchorage of HIV on permissive cells leads to co-aggregation of viral particles with surface nucleolin at membrane raft microdomains. Nisole S, Krust B, Hovanessian AG, Exp Cell Res 2002 276 155 173 10.1006/excr.2002.5522 12027446 (Pubitemid 34969310)
35. N-Glycosylation influences the structure and self-association abilities of recombinant nucleolin. Losfeld ME, Leroy A, Coddeville B, Carpentier M, Mazurier J, Legrand D, FEBS J 2011 278 2552 2564 10.1111/j.1742-4658.2011.08180. x 21575138
36. The glycine-rich domain of nucleolin has an unusual supersecondary structure responsible for its RNAHelix- destabilizing properties. Ghisolfi L, Joseph G, Amalric F, Erard M, J Biol Chem 1992 267 2955 2959 1737751
37. Nucleolin is a sequence-specific RNA-binding protein: characterization of targets on pre-ribosomal RNA. Ghisolfi-Nieto L, Joseph G, Puvion-Dutilleul F, Amalric F, Bouvet P, J Mol Biol 1996 260 34 53 10.1006/jmbi.1996.0380 8676391 (Pubitemid 26241389)
38. High affinity interactions of nucleolin with G-G-paired rDNA. Hanakahi LA, Sun H, Maizels N, J Biol Chem 1999 274 15908 15912 10.1074/jbc.274.22.15908 10336496 (Pubitemid 29254971)
39. Nucleolin interacts with several ribosomal proteins through its RGG domain. Bouvet P, Diaz J-J, Kindbeiter K, Madjar J-J, Amalric F, J Biol Chem 1998 273 19025 19029 10.1074/jbc.273.30.19025 9668083 (Pubitemid 28366294)
40. Macrophage scavenger receptor and host-derived ligands. Pluddemann A, Neyen C, Gordon S, Methods 2007 43 207 217 10.1016/j.ymeth.2007.06.004 17920517 (Pubitemid 47499075)
41. Targeting surface nucleolin with a multivalent pseudopeptide delays development of spontaneous melanoma in RET transgenic mice. El Khoury D, Destouches D, Lengagne R, Krust B, Hamma-Kourbali Y, Garcette M, Niro S, Kato M, Briand JP, Courty J, Hovanessian AG, Prévost-Blondel A, BMC Cancer 2012 24 325
42. Suppression of tumorigenicity of rhabdoid tumor derived G401 cells by the multivalent HB-19 pseudopeptide that targets surface nucleolin. Krust B, El Khoury D, Soundaramourty C, Nondier I, Hovanessian AG, Biochimie 2011 93 426 433 10.1016/j.biochi.2010.10.015 21040752
43. Identification of V3 loop-binding proteins as potential receptors implicated in the binding of HIV particles to CD4+ cells. Callebaut C, Blanco J, Benkirane N, Krust B, Jacotot E, Guichard G, Seddiki N, Svab J, Dam E, Muller S, Briand JP, Hovanessian AG, J Biol Chem 1998 273 21988 21997 10.1074/jbc.273.34.21988 9705340 (Pubitemid 28405379)
44. Cell surface-localized nucleolin is a eukaryotic receptor for the adhesin intimin-gamma of enterohemorrhagic Escherichia coli O157:H7. Sinclair JF, O'Brien AD, J Biol Chem 2002 277 2876 2885 10.1074/jbc.M110230200 11704679 (Pubitemid 34953321)
45. The cell surface expressed nucleolin is a glycoprotein that triggers calcium entry into mammalian cells. Losfeld ME, Khoury DE, Mariot P, Carpentier M, Krust B, Briand JP, Mazurier J, Hovanessian AG, Legrand D, Exp Cell Res 2009 315 357 369 10.1016/j.yexcr.2008.10.039 19026635
46. At the heart of the nucleolus. Jordon G, Nature 1987 329 489 490 10.1038/329489a0 3309675
47. Association of protein C23 with rapidly labeled nucleolar RNA. Herrera AH, Olson MOJ, Biochemistry 1986 25 6258 6264 10.1021/bi00368a063 3790520 (Pubitemid 17204064)
48. Major nucleolar proteins shuttle between nucleus and cytoplasm. Borer RA, Lehner CF, Eppenberger HM, Nigg EA, Cell 1989 56 379 390 10.1016/0092-8674(89) 90241-9 2914325
49. Basic fibroblast growth factor enters the nucleolus and stimulates the transcription of ribosomal genes in ABAE cells undergoing Go-G1 transition. Bouche G, Gas N, Prats H, Baldin V, Tauber JP, Teissie J, Amalric F, Proc Natl Acad Sci USA 1987 84 6770 6774 10.1073/pnas.84.19.6770 3477808
50. Nucleolin from Xenopus laevis: cDNA cloning and expression during development. Caizergues-Ferrer M, Mariottini P, Curie C, Lapeyre B, Gas N, Amalric F, Amaldi F, Genes Dev 1989 3 324 333 10.1101/gad.3.3.324 2656405
51. Repeat peptide motifs which contain beta-turns and modulate DNA condensation into chromatin. Erard M, Lakhdar-Ghazal F, Amalric F, Eur J Biochem 1990 191 19 26 10.1111/j.1432-1033.1990.tb19088.x 2379500 (Pubitemid 20219025)
52. Nucleolin is one component of the B-cell specific transcription factor and switch region binding protein, LR1. Hanakahi LA, Dempsey LA, Li MJ, Maizels N, Proc NatI Acad Sci USA 1997 94 3605 3610 10.1073/pnas.94.8.3605 (Pubitemid 27180419)
53. A B-cell-specific DNA recombination complex. Borggrefe T, WabI M, Akhmedov AT, Jessberger R, J Biol Chem 1998 273 17025 17035 10.1074/jbc.273.27. 17025 9642267 (Pubitemid 28311736)
54. Autoantibodies to nucleolin in systemic lupus erythematosus and other diseases. Minota S, Jarjour WN, Suzuki N, Nojima Y, Roubey RA, Mimura T, Yamada A, Hosoya T, Takaku F, Winfield JB, J Immunol 1991 146 2249 2252 2005395
55. Immunodominant RNA recognition motifs of human nucleolin/C23. Valdez BC, Henning D, Busch RK, Srivastava M, Busch H, Mol Immunol 1995 32 1207 1213 10.1016/0161-5890(95)00093-3 8559145 (Pubitemid 26015102)
56. Human DNA helicase IV is nucleolin, an RNA helicase modulated by phosphorylation. Tuteja N, Huang NW, Skopac D, Tuteja R, Hrvatic S, Zhang J, Ponger S, Joself G, Faucher C, Amalric F, Gene 1995 160 143 148 10.1016/0378-1119(95)00207-M 7642087
57. Inhibition of DNA unwinding and ATPase activities of human DNA helicase II by chemotherapeutic agents. Tuteja N, Phan TN, Tuteja R, Ochem A, Falaschi A, Biochem Biophys Res Commun 1997 236 636 640 10.1006/bbrc.1997.7021 9245703 (Pubitemid 27384679)
58. Purification and characterization of nucleolin and its identification as a transcription repressor. Yang TH, Tsai WH, Lei HY, Lai MY, Chen DS, Yeh NH, Lee SC, Mol Cell Biol 1994 14 6068 6074 10.1128/MCB.14.9.6068 8065340
59. Inactivation of nucleolin leads to nucleolar disruption, cell cycle arrest and defects in centrosome duplication. Ugrinova I, Monier K, Ivaldi C, Thiry M, Storck S, Mongelard F, Bouvet P, BMC Mol Biol 2007 8 66 10.1186/1471-2199-8-66 17692122 (Pubitemid 47423728)
60. DNA damage-induced translocation of S100A11 into the nucleus regulates cell proliferation. Gorsler T, Murzik U, Ulbricht T, Hentschel J, Hemmerich P, Melle C, BMC Cell Biol 2010 11 100 10.1186/1471-2121-11-100 21167017